AE-09-SG21_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, Tarenflurbil, Antiamyloidogenic Agents;NF-kappaB (NFKB) Modulators;gamma-Secretase Inhibitors targeting PTGS1, PTGS2, APP (Novartis, 92337)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/92337
Similar Terms
Downloads & Tools

Genes

9 genes differentially expressed following the AE-09-SG21_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
MANBAL mannosidase, beta A, lysosomal-like 0.419723
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 0.251484

decreased expression

Symbol Name Standardized Value
COX6A1 cytochrome c oxidase subunit VIa polypeptide 1 -1.15656
DUSP8 dual specificity phosphatase 8 -0.394395
EIF2B3 eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa -0.334673
UBE2L6 ubiquitin-conjugating enzyme E2L 6 -0.291876
PSMD3 proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 -0.251484
NUTF2 nuclear transport factor 2 -0.245424
LSM6 LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae) -0.22152